STOCK TITAN

Pro-Dex director (NASDAQ: PDEX) sells 998 shares in open market trade

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Pro-Dex Inc director Domingo Angelita Rebamontan reported an open-market sale of 998 shares of Common Stock on March 16, 2026, at $47.2400 per share. Following this transaction, the director directly holds 18,779 shares of Pro-Dex common stock.

Positive

  • None.

Negative

  • None.
Insider Domingo Angelita Rebamontan
Role Director
Sold 998 shs ($47K)
Type Security Shares Price Value
Sale Common Stock 998 $47.24 $47K
Holdings After Transaction: Common Stock — 18,779 shares (Direct)
Footnotes (1)
Shares sold 998.0000 shares Open-market sale of Common Stock on 2026-03-16
Sale price $47.2400 per share Price per share for the 998.0000-share sale
Shares owned after sale 18779.0000 shares Directly held by the reporting person following the transaction
Net insider share change 998 shares Net-sell shares in this reported Form 4 transaction
open-market sale financial
"Transaction action described as an open-market sale of shares"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
non-derivative financial
"Transaction type is classified as non-derivative Common Stock"
Common Stock financial
"Security title reported for the transaction is Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Pro-Dex (PDEX) report for March 16, 2026?

Pro-Dex (PDEX) reported that director Domingo Angelita Rebamontan executed an open-market sale of 998 shares of Common Stock on March 16, 2026, at a price of $47.2400 per share, according to the Form 4 insider transaction disclosure.

How many Pro-Dex (PDEX) shares did the director sell and at what price?

The director sold 998 shares of Pro-Dex (PDEX) Common Stock at $47.2400 per share. This was reported as an open-market or private transaction sale and is categorized as a non-derivative transaction in the Form 4 data.

How many Pro-Dex (PDEX) shares does the director hold after the sale?

After the reported transaction, the director directly holds 18,779 shares of Pro-Dex (PDEX) Common Stock. This post-transaction balance reflects the holdings remaining following the 998-share open-market sale disclosed in the insider filing.

Is the reported Pro-Dex (PDEX) insider transaction in derivatives or common stock?

The reported Pro-Dex (PDEX) insider transaction involves Common Stock and is classified as non-derivative. No derivative securities, such as options or warrants, are listed in this Form 4 transaction, and the derivativeSummary section shows no derivative positions in this filing.

What is the net share change from this Pro-Dex (PDEX) insider transaction?

The Form 4 shows a net-sell of 998 shares of Pro-Dex (PDEX) Common Stock. Transaction summary data indicate one sale transaction, with 998 shares sold and no offsetting purchases or derivative exercises included in this particular insider report.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Domingo Angelita Rebamontan

(Last)(First)(Middle)
2361 MCGAW AVENUE

(Street)
IRVINE CALIFORNIA 92614

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PRO DEX INC [ PDEX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/16/2026S998D$47.2418,779D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Alisha Charlton as attorney-in-fact for Angelita Domingo07/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)